Blog
05-11-2023Cross-posted from FDA News Release Today, the U.S. Food and Drug Administration finalized recommendations for a...
FDA News Release
FDA Finalizes Move to Recommend Individual Risk Assessment to Determine Eligibility for Blood Donations - Blog
FDA Proposes Individual Risk Assessment for Blood Donations, While Continuing to Safeguard U.S. Blood Supply 01-27-2023Cross-posted from FDA News Release The U.S. Food and Drug Administration today announced it is proposing a chan... - Blog
FDA Approves New HIV Drug for Adults with Limited Treatment Options 01-04-2023Cross-posted from FDA News Release [On December 22, 2022], the U.S. Food and Drug Administration approved Sunle... - Blog
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention 12-21-2021 - Blog
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic 10-03-2019 - Blog
FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment 04-09-2019 - Blog
FDA in Brief: FDA announces pilot program with World Health Organization to expedite review of HIV drug applications 11-30-2018 - Blog
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection 06-30-2016 - Blog
Califf, FDA top officials call for sweeping review of agency opioids policies 02-05-2016Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among perso… - Blog
FDA updates blood donor deferral policy to reflect the most current scientific evidence and continue to ensure the safety of the U.S. blood supply 12-21-2015 - Blog
FDA Commissioner Margaret A. Hamburg's statement on FDA’s blood donor deferral policy for men who have sex with men 12-23-2014 - Blog
FDA approves Sovaldi for chronic hepatitis C 12-09-2013